The current neural transplantation strategy for Parkinson's disease (PD) involves the dopaminergic reinnervation of the striatum (STR). Although up to 85% reinnervation of the STR has been attained by neural transplantation, functional recovery in animal models and transplanted patients is incomplete. This limitation may be due to an incomplete restoration of the dopaminergic input to other basal ganglia structures such as the external segment of the globus pallidus (GPe, homologue of the rodent GP), which normally receives dopaminergic input from the substantia nigra (SN). As part of our investigation into a multiple grafting strategy for PD, we have explored the effects of dopaminergic grafts in the GP of rodents with unilateral 6-hydroxydopamine (6-OHDA) lesions. In this experiment, lesioned rats received either 300,000 fetal ventral mesencephalic (FVM) cells or a sham injection into the GP. Functional assessment consisted of rotational behavior at 3 and 6 weeks posttransplantation. A fluorogold tracer study was conducted to rule out any behavioral improvement due to striatal outgrowth of the GP graft. Sections were stained for glial fibrillary acidic protein (GFAP) to assess the degree of trauma in the GP by the graft in comparison to the sham injection. Immunohistochemistry for tyrosine hydroxylase (TH) was performed after transplantation to assess graft survival. Animals with GP grafts demonstrated a significant improvement in rotational behavior at 3 and 6 weeks posttransplantation ( p < 0.05) while sham control animals did not improve. All animals receiving FVM cells showed TH-immunoreactive grafts in the GP posttransplantation. TH-positive neurons in the GP showed no double labeling with an intrastriatal injection of fluorogold, indicating that behavioral improvement was not due to striatal innervation by the GP graft. These observations suggest that functional recovery was the result of dopaminergic reinnervation of the GP and that this nucleus may be a potential target for neural transplantation in clinical PD.
INTRODUCTION
clinical transplantation for PD may be the inability of striatal grafts to reinnervate other basal ganglia nuclei The present clinical neural transplantation strategy that normally receive dopaminergic input from the subfor Parkinson's disease (PD) involves grafting dopaminstantia nigra pars compacta (SNc). ergic cells into the striatum (STR), the target site of the The degeneration of the SNc in PD does not exclumajority of nigrostriatal efferents. In animal models of sively affect the STR, which receives the bulk of dopa-PD, grafting into the STR has achieved up to 85% reinminergic afferents. In addition to the STR, the SNc nornervation of the STR (51); however, functional recovery mally sends dopaminergic input to the substantia nigra remains incomplete (25, 42, 43, 51) . The clinical results of pars reticulata (SNr), the subthalamic nucleus (STN), neural transplantation in PD patients correlate well with and both the internal (GPi) and external (GPe) segments the experience in animal models, as the clinical efficacy of the globus pallidus. Anterograde tracer studies and of intrastriatal neural transplantation has been limited tyrosine hydroxylase (TH) immunohistochemical stain- (11, (14) (15) (16) 22, 24, 33, 35, 49, 50 ). An important reason for ing have demonstrated dopaminergic projections to the limitation in functional recovery in experimental and these areas in animal, human, and nonhuman primate 120 BARTLETT AND MENDEZ studies (9, 20, 29, 32, 46) . In MPTP-treated primates, mopaminergic grafts and its effects on rotational behavior in the unilateral rodent 6-OHDA lesion model of PD. tor symptoms of PD did not occur until dopamine depletion was observed in extrastriatal regions, such as the This study is part of our systematic exploration of a multitarget strategy aimed at repairing the basal ganglia GPe (45) .
TH-immunoreactive fibers have been identified in the dopaminergic circuitry in the PD brain (2, 3, 38, 39) . human GPe (homologue of the rodent GP) (9, 23) . Land-MATERIALS AND METHODS mark studies using the glyoxylic acid vibratome techExperimental Design nique have aided in the visualization of collateral branches from the nigrostriatal axons into the GPe (31) . It has Eighteen female Wistar rats (200-225 g; Charles River, been suggested that the entire catecholaminergic termiSt. Constant, Quebec) received 6-OHDA lesions to the nal plexus of the GPe originates from SNc dopaminergic right ascending nigrostriatal pathway. Rats demonstratneurons (32) . Post mortem human brain studies of indiing rotational behavior were randomly divided into three viduals with no clinical or pathological evidence of neugroups. Each rat received either a transplant of 300,000 rological disorders show strong evidence of dopaminerfetal ventral mesencephalic (FVM) cells to the GP (n = gic projections from the SNc to the GPe (9,46). Thin, 10), a sham transplant to the GP (n = 5), or no transplant varicose fibers projecting to the GPe were found to be (lesioned controls; n = 3). Rats were housed two animals TH immunoreactive. These TH-immunoreactive fibers per cage at 21°C on a 12-h light/dark cycle with food travel to the GPe via two principal pathways: the lenticand water ad libitum. All procedures outlined were perular fasciculus and ansa lenticularis (9, 46) . In the squirformed according to the guidelines of the Canadian rel monkey, fibers originating from the SNc and ventral Council on Animal Care and the University Committee tegmentum projecting to the GPe stain for TH but not on Laboratory Animals. dopamine-B-hydroxylase, specifying the dopaminergic 6-OHDA Lesioning and Rotational Behavior quality of these catecholaminergic neurons (44) . Loss of dopaminergic innervation to the GP in rodents has been Rats were anesthetized intramuscularly with 2.0 ml/ shown to be important, as intrapallidal dopamine adminkg of a ketamine/xylazine/acepromazine mixture [25% istration restores motor deficits in the 6-OHDA hemiparketamine hydrochloride (Ketalean, MTC Pharmaceutikinsonian rodent model (18) . Pharmacological blockade cals); 6% xylazine (Rompun, Miles Canada); 2.5% aceof the GP has been demonstrated to cause ipsilateral ropromazine maleate (Acepromazine, Wyeth-Ayerst Cantation, similar to nigral lesions (10) . Unilateral injections ada); in 0.9% saline]. They were then lesioned with two of haloperidol into the GP induced a more rapid, intense stereotaxic injections of 6-OHDA (3.6 µg of 6-OHDA ipsilateral rotation than injections into the caudate-putaHBr/µl in 2.0 mg/ml of L-ascorbate in 0.9% saline; men (10) . Furthermore, specific D1 and D2 receptor Sigma) at the following two sites: a) 2. All coordinates are shown that the GPe is a major relay nucleus in the indiin millimeters from bregma and the surface of the brain rect basal ganglia pathway [for review, see (48) ]. By at bregma. Using a 10-µl Hamilton syringe at a rate of sending afferents to the STN, the GPe plays a major role 1.0 µl/min, 6-OHDA was injected and the cannula left in regulating important relays to output nuclei of the in place for five minutes before being retracted. basal ganglia. It is known that 6-OHDA lesions to the To assess the extent of the lesion, rotational behavior SNc lead to changes in both c-fos and cytochrome oxiwas assessed 14 days after surgery using a computerized dase (CO) activity in the ipsilateral GP of hemi-lesioned video monitor (Videomex-V, Columbus Instruments) to rodents; however, although c-fos activity is markedly recount ipsilateral rotations. Animals were injected with duced, intrastriatal dopaminergic grafts do not normalize amphetamine (5 mg/kg, IP) and rotations were counted CO activity (40).
for 60 min following injection. Only animals exhibiting It is clear that the GPe is an important component of a mean ipsilateral rotational score of over eight rotathe dopaminergic basal ganglia circuitry. In this regard, tions/minute were included in the study. the GPe may be an appropriate target for neural transTransplantation of Fetal Nigral Cells plantation aimed at repairing the dopaminergic circuitry.
Restoration of dopaminergic innervation to the GP/GPe
For transplantation to the GP, ventral mesencephalic (VM) tissue was dissected from fetuses of gestational may optimize functional recovery in animal models of PD, and potentially increase the clinical efficacy of neuday 14 Wistar rats in Dulbecco's modified essential medium (DMEM; Life Technologies) under aseptic condiral transplantation in PD patients. The present study focuses on the reinnervation of the rodent GP by fetal dotions. Cells were stored overnight at 4°C in a calcium-free phosphate-buffered hibernation medium containing and perfused transcardially with 200 ml of 0.1 M phosphate buffered saline (PBS) followed by 250 ml of 4% the following: 30 mM KCl, 5 mM glucose, 0.24 mM MgCl 2 , 5 mM NaH 2 PO 4 , 20 mM lactic acid, 32.18 mM paraformaldehyde in 0.1 M phosphate buffer (PB) for 15 min. The brains were extracted and postfixed over-KOH, and 164.7 mM sorbitol, at a pH of 7.4. Cells were prepared using DMEM and dissociated in 0.1% trypnight in 4% paraformaldehyde in 0.1 M PB before being stored overnight in 30% sucrose in 0.1 M PBS. Coronal sin (Sigma)/0.05% deoxyribonuclease (DN-25; Sigma)/ DMEM at 37°C for 20 min to make a homogenous cell sections 40 µm thick were cut with a freezing microtome and serially collected in 0.1 M PB. suspension. The cell concentration used for transplantation was 200,000 cells/µl with a cell viability of 98% as TH immunohistochemistry was performed using a primary rabbit anti-TH antibody (Ab) (1:2500; Pel Freeze). assessed by the trypan blue dye exclusion method. Cells were stereotaxically implanted into the GP using the miBriefly, one in four sections was first incubated in a solution of 10% methanol and 3% hydrogen peroxide, then crografting technique (1,34, [36] [37] [38] 40 ). An equal volume of medium was injected into sham controls at the same blocked with a solution containing 0.3% Triton X-100 (Sigma) and 5% normal swine serum (NSS) in 0.1 M coordinates. A group of lesioned animals was also assessed. Under ketamine/xylazine/acepromazine anesthe-PB. Sections were incubated overnight at room temperature in the primary Ab. Binding was visualized by using tic, a total of 300,000 cells (150,000 cells/site) were injected into the GP at the following two sites: a) AP:
the secondary Ab, biotinylated swine anti-rabbit IgG (1:500; Dako) followed by a streptavidin biotinylated −0.9, ML: −2.9, DV: −6.9, toothbar: −3.3; b) AP: −0.8, ML: −2.6, DV: −6.5, toothbar: −3.3. All coordinates are horseradish peroxidase (HRP) complex kit (Dako). Peroxidase activity was visualized by the addition of 3,3′-in millimeters from bregma and the surface of the skull at bregma. Using a 2.0-µl Hamilton syringe at a rate of diaminobenzidine (DAB) and hydrogen peroxide in 0.1 M PB. For double-labeling the fluorogold-injected ani-1.0 µl/min, the cell suspension was injected and the cannula left in place for 5 min before being retracted. mals, TH immunohistochemistry was performed using the primary antibody procedure outlined above, followed Behavioral Testing by a secondary CyTM3-conjugated goat anti-rabbit IgG (1:100; Jackson ImmunoResearch). Control sections were Following transplantation, rotational behavior was evaluated according to the protocol mentioned above.
also incubated without primary antibody to determine nonspecific binding and general background staining. Statistical analysis was performed using a two-way analysis of variance (ANOVA; p < 0.05), and Tukey's post
To assess the degree of gliosis to the STR by either the transplant or the sham injection, glial fibrillary acidic hoc test.
protein (GFAP) immunohistochemistry was performed Fluorogold Tracer Injection using a primary mouse anti-GFAP-GAS Ab (1:150; Novacastra). One in four sections was first incubated in a Three of the 10 animals receiving FVM transplants to the GP received fluorogold (2% fluorogold in 0.9% solution of 10% methanol and 3% hydrogen peroxide, then blocked with a solution containing 0.3% Triton Xsaline; Fluorochrome Inc.) injections into the STR at 6 weeks following cell transplantation and were perfused 100 and 5% normal horse serum (NHS) in 0.1 M PBS. Sections were incubated overnight at room temperature 10 days later, in accordance with previous fluorogold experiments conducted in our laboratory (36) . Briefly, in the primary Ab. Binding was visualized by using the secondary Ab, biotinylated horse anti-mouse IgG To compare the sections stained for GFAP, a densitometry software program (Scion Image) was used to Postgraft Histological Assessment calculate the relative optical density of GFAP-stained and Immunohistochemistry sections. Immunostaining within a window encompassing the grafted area in the GP was analyzed in each Six weeks following cell transplantation, all animals except for those receiving fluorogold injection (see Flustained section converted to a grayscale, measuring the area meeting the standardized threshold density. The orogold Tracer Injection section) were euthanized with an overdose of ketamine/xylazine/acepromazine mixture mean of eight measurements was used for statistical analysis. Using a two-way ANOVA ( p < 0.05) and Tupositive cells residing mainly at the periphery of the graft. The dopaminergic grafts were contained within key's post hoc test, statistical analysis for betweengroup and within-group differences was performed.
the GP and did not spread to the adjacent STR (Fig.  1A, C, E) . Sham-injected animals showed an occasional RESULTS residual TH-positive fiber; no TH-positive cell bodies were seen (Fig. 1B, D, F) . Caudal sections of the brain Dopaminergic Graft Morphology stem showed complete lesions of the ipsilateral SN with All animals receiving FVM tissue had surviving grafts absence of TH immunostaining in both the SNc and SNr as demonstrated by rich TH-immunohistochemical stain- (Fig. 2) . ing. Graft deposits were clearly identified by a dense network of TH-stained fibers and cell bodies. After 6 Double-Labeling With Fluorogold and TH weeks, rats with dopaminergic grafts displayed extensive fiber outgrowth confined to the GP. The grafts were Animals receiving fluorogold injections into the STR did not show double-labeled cells in the GP (Fig. 3C) . spherical in shape, with dense clusters of healthy TH- Grafted neurons showed robust TH staining and fiber plantation compared to postlesion rotational scores (Fig.  5) . Control animals receiving sham injections and nigral outgrowth within the GP (Fig. 3A, C) . However, none of the transplanted FVM neurons stained with TH dem-6-OHDA lesions had no significant change in rotational behavior at 3 or 6 weeks. onstrated fluorogold labeling (Fig. 3C) , suggesting that the transplanted FVM neurons did not grow processes DISCUSSION into the STR. Some resident non-TH-positive GP cells showed fluorogold staining at the transplant site (Fig. This study has demonstrated that dopaminergic rein-3B). A clear difference in size of the transplanted neunervation of the GP by FVM grafts improves rotational rons in comparison with fluorogold-labeled resident behavior in 6-OHDA lesioned rats. As grafting into the cells of the GP was observed (Fig. 3) . Grafted neurons STR can also improve rotational behavior, the fiber outwere identified by their larger size and robust TH growth from the GP was carefully monitored. The imstaining.
provement in function appears to be the result of reinnervation of the GP alone as the tracing studies did not GFAP Optical Density reveal double-labeled transplanted cells in the GP when Sections labeled for GFAP demonstrated diffuse gliofluorogold was injected into the STR. The lack of fluorsis in the GP in both grafted (Fig. 4A, C) and sham ogold labeling suggests that the functional recovery was transplanted animals (Fig. 4B, D) . Although animals not due to fiber outgrowth of the graft into the STR, with sham injections appeared to have slightly more although it may be is possible that the fluorogold deposit dense GFAP immunoreactivity than the grafted animals was too distant from the transplant, thus not transported (Fig. 4B, D) with an apparent increase in reactive astroto the grafted cells, or that the three animals injected cytes, optical density scores revealed no significant difdid not fully represent the whole group. The rotational ference between the grafted (37264.38 ± 5384.59) and behavior improvement followed a gradual progression sham transplanted (34421.21 ± 4289.08) animals ( p > over 6 weeks. This correlates well with the model of 0.05).
graft maturation proposed by Hagell and Brundin (19). Therefore, it is likely that the functional improvement Rotational Behavior was due to graft maturation (i.e., fiber outgrowth in the GP) and not simply diffusion of dopamine into the STR. Animals receiving grafts to the GP had a significant reduction in amphetamine-induced rotational behavior at Lesion of the GP by the transplant injection is also unlikely to be responsible for behavioral improvement be-3 weeks ( p < 0.05) and 6 weeks ( p < 0.05) after trans-cause animals with sham transplants did not exhibit behavioral improvement. Furthermore, sections stained for GFAP demonstrated that grafted animals did not exhibit an increase of reactive gliosis compared with sham transplanted animals. Reactive gliosis is a good marker for trauma or following stressful conditions (9, 10) . These results indicate that behavioral improvement in grafted animals was unlikely due to a lesion effect of the implantation of the graft.
The GPe is a major contributor to output structures of the basal ganglia. The standard model of the basal ganglia function suggests that the GPe has inhibitory control over the STN, a major relay to output nuclei in the basal ganglia (12). According to this model, the GPe normally displays tonic GABAergic inhibition of the STN. The GPe receives afferents from the STR, which is regulated by the dopaminergic input from the SNc. This model suggests that in PD, the GPe is inhibited by the lack of dopaminergic input to the STR from the SNc. This altered pallidal state results in disinhibition of the STN and subsequent inhibition of thalamic output to the cortex (12). However, this model is highly oversimplified. The GPe is also regulated by dopaminergic projections from the SNc (9, 32, 44, 46) . Nigrostriatal axons and collateral branches from the SN into the GPe have been visualized using the glyoxylic acid vibratome technique (31) . It has been postulated that all the catecholaminergic axons in the GPe originate from the SN (32) .
According to c-fos and CO studies, the GP appears to be altered after 6-OHDA lesions. Intrastriatal dopaminergic grafts do not restore the altered GP to its normal state according to CO measures but appear to reduce c-fos to normal levels (40). However, infusion of dopamine into the GP results in behavioral improvement in the rodent model (18) , indicating the importance of dopaminergic innervation of the GP. Furthermore, MPTPtreated animals display motor symptoms of PD only upon dopamine depletion in extrastriatal regions, such as the GPe (45) . Overall, the GPe has been shown to be important in the regulation of basal ganglia structures in the classical model of basal ganglia function and studies revealing the dopaminergic innervation of the GPe by the SN. The current neural transplantation strategy for PD fails to restore dopaminergic input to the GP/GPe, which may limit functional recovery in experimental and clinical neural transplantation. In the present study, transplants to the GP alone improved rotational behavior to for the control of different PD symptoms, such as the 
